Moxifloxacin HCL 400 MG tablet UD 50S
Ended Awarded Last action
- Contract number
- SPE2DR26FU8XE
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $30,305
Award facts
- Contract value 100% obligated
- $30,304.88 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a $30,304.88 delivery order to Amerisourcebergen Drug Corp on February 22, 2026, for moxifloxacin HCL 400 mg tablets (UD 50s).
Place of performance is Conshohocken, PA. The order is firm fixed price with an ultimate completion date of February 23, 2026. No set-aside was used.
Quick answers
Who was awarded contract SPE2DR26FU8XE?
SPE2DR26FU8XE was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on February 22, 2026.
How much is contract SPE2DR26FU8XE worth?
The government has obligated $30,305 on SPE2DR26FU8XE.
Is contract SPE2DR26FU8XE an order under another contract?
Yes. SPE2DR26FU8XE is a delivery order under SPE2DR25D3112, an indefinite delivery contract.
Was contract SPE2DR26FU8XE competed?
The extent of competition for SPE2DR26FU8XE was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award